RNA Atrium Therapeutics, Inc.
Nasdaq · SEC CIK 2093101 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 19 since 2026-03-02, latest 2026-09-22 16:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Younis Husam | CSO | — | — |
| Hoyos Rocio Martin | Chief Strategy Off | — | — |
| Winslow Brendan R. | CFO | — | — |
| Kenney Stephanie | See Remarks | — | — |
| Gallagher Kathleen P. | See Remarks, Dir | — | — |
| Flanagan W. Michael | Dir | — | — |
| Hughes Steven George | Chief Medical Off | — | — |
| Boyce Sarah | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 16:24 | 2026-09-18 | RNA | Younis Husam | CSO | F - Tax | $8.95 | -11.2K | 41.4K | -21% | -$100.4K | |
| 2026-09-22 16:23 | 2026-09-18 | RNA | Hughes Steven George | Chief Medical Off | F - Tax | $8.95 | -21.5K | 51.6K | -29% | -$192.1K | |
| 2026-09-22 16:20 | 2026-09-18 | RNA | Flanagan W. Michael | Dir | F - Tax | $8.95 | -22.8K | 32.0K | -42% | -$204.2K | |
| 2026-09-22 16:20 | 2026-09-18 | RNA | Boyce Sarah | Dir | F - Tax | $8.95 | -126.4K | 138.7K | -48% | -$1.13M | |
| 2026-09-22 16:18 | 2026-09-18 | RNA | Kenney Stephanie | See Remarks | F - Tax | $8.95 | -2,375 | 33.1K | -7% | -$21.3K | |
| 2026-09-22 16:17 | 2026-09-18 | RNA | Gallagher Kathleen P. | See Remarks, Dir | F - Tax | $8.95 | -11.6K | 119.7K | -9% | -$104.1K | |
| 2026-09-22 16:17 | 2026-09-18 | RNA | Winslow Brendan R. | CFO | F - Tax | $8.95 | -6,742 | 36.9K | -15% | -$60.3K | |
| 2026-09-22 16:15 | 2026-09-18 | RNA | Hoyos Rocio Martin | Chief Strategy Off | F - Tax | $8.95 | -8,320 | 38.3K | -18% | -$74.5K | |
| D | 2026-04-22 17:54 | 2026-04-20 | RNA | Kenney Stephanie | See Remarks | A - Grant | $0.00 | +30.0K | 35.5K | +549% | $0 |
| D | 2026-04-22 17:54 | 2026-04-20 | RNA | Hughes Steven George | Chief Medical Off | A - Grant | $0.00 | +30.0K | 73.1K | +70% | $0 |
| D | 2026-04-22 17:53 | 2026-04-20 | RNA | Winslow Brendan R. | CFO | A - Grant | $0.00 | +30.0K | 43.6K | +221% | $0 |
| D | 2026-04-22 17:43 | 2026-04-20 | RNA | Gallagher Kathleen P. | See Remarks, Dir | A - Grant | $0.00 | +102.5K | 131.4K | +355% | $0 |
| D | 2026-04-22 17:41 | 2026-04-20 | RNA | Hoyos Rocio Martin | Chief Strategy Off | A - Grant | $0.00 | +30.0K | 46.7K | +180% | $0 |
| D | 2026-04-22 17:40 | 2026-04-20 | RNA | Younis Husam | CSO | A - Grant | $0.00 | +30.0K | 52.7K | +132% | $0 |
Purchase Sale Sale after option exercise All abbreviations